MM&M Articles
- Which drugmakers have the healthiest presence on social media?
- Five things for pharma marketers to know: Monday, September 26, 2016
- Uber partners with startup to take patients to the doctor
- Drugmakers set their sights on the next potential blockbuster disease: NASH
- Five things for pharma marketers to know: Tuesday, September 27, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- When it comes to professional ads, print makes its comeback
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Five things for pharma marketers to know: Friday, September 30, 2016
- Sharecare aims to drive behavior change with VR acquisition
- Drugmakers set their sights on the next potential blockbuster disease: NASH
- Five things for pharma marketers to know: Thursday, September 29, 2016
- BBDO picks up Neulasta; FCB gains Galderma and Sandoz work in the U.S.
